Contaminated Heparin Associated with Adverse Clinical Events and Activation of the Contact System
Author(s) -
Takashi Kishimoto,
Karthik Viswanathan,
Tanmoy Ganguly,
Subbiah Elankumaran,
Sean G. Smith,
Kevin D. Pelzer,
Jonathan C. Lansing,
Nammalwar Sriranganathan,
Ganlin Zhao,
Zoya Galcheva-Gargova,
Ali AlHakim,
Gregory Scott Bailey,
Blair A. Fraser,
Sucharita Roy,
Thomas Rogers-Cotrone,
Lucinda F. Buhse,
Mark T. Whary,
James G. Fox,
Moheb Nasr,
Gerald J. Dal Pan,
Zachary Shriver,
Róbert Langer,
Ganesh Venkataraman,
K. Frank Austen,
Janet Woodcock,
Ram Sasisekharan
Publication year - 2008
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa0803200
Subject(s) - heparin , medicine , complement system , kallikrein , chondroitin sulfate , pharmacology , mediator , anaphylatoxin , adverse effect , factor xii , immunology , glycosaminoglycan , biochemistry , coagulation , chemistry , antibody , enzyme , anatomy
There is an urgent need to determine whether oversulfated chondroitin sulfate (OSCS), a compound contaminating heparin supplies worldwide, is the cause of the severe anaphylactoid reactions that have occurred after intravenous heparin administration in the United States and Germany.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom